3/4/20 17:01 | 3/2/20 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelly James Patrick | DC | O | EVP,CFO | S.m | -195 | 10.36 | 0 | -19 | -9 | 187 | D | | | | | | | | | | | | | | |
1/6/20 17:25 | 1/2/20 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelly James Patrick | DC | O | EVP,CFO | S | -64 | 15.94 | 0 | -4 | -2 | 206 | D | | | | | | | | | | | | | | |
3/4/19 17:06 | 3/1/19 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelly James Patrick | DC | O | EVP,CFO | S.m | -274 | 19.98 | 0 | -14 | -6 | 210 | D | | | | | | | | | | | | | | |
1/4/19 16:33 | 1/2/19 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelly James Patrick | DC | O | EVP,CFO | S.m | -160 | 26.37 | 0 | -6 | -3 | 193 | D | | | | | | | | | | | | | | |
3/2/18 17:34 | 3/1/18 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelly James Patrick | DC | O | EVP,CFO | S.d | -160 | 18.72 | 0 | -9 | -4 | 200 | D | | | | | | | | | | | | | | |
1/4/18 17:12 | 1/2/18 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelly James Patrick | DC | O | EVP,CFO | S.d | -140 | 15.35 | 0 | -9 | -5 | 168 | D | | | | | | | | | | | | | | |
1/5/17 17:01 | 1/3/17 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelly James Patrick | DC | O | SVP,CFO, | S.d | -169 | 15.51 | 8 | -11 | -14 | 70 | D | 11 | 76 | 37 | -2 | -7 | -1 | 4 | -1 | -3 | -11 | -13 | -15 | | |
1/6/16 19:09 | 1/4/16 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelly James Patrick | DC | O | SVP,CFO, | S.d | -86 | 8.96 | 8 | -10 | -14 | 61 | D | -28 | -37 | -27 | -25 | -6 | 5 | -6 | -6 | -4 | 4 | 1 | -1 | 33 | 80 |
3/12/15 18:53 | 3/10/15 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelly James Patrick | DC | O | SVP,CFO, | S.d | -131 | 10.53 | 11 | -12 | -19 | 53 | D | 187 | -30 | -16 | -12 | -7 | -6 | -3 | 1 | 0 | -6 | -8 | 24 | 19 | -26 |
11/21/13 20:00 | 11/19/13 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelly James Patrick | DC | O | SVP,CFO, | S | -40 | 12.07 | 33 | -3 | -10 | 29 | D | 120 | 254 | 63 | 6 | 15 | 62 | 71 | -20 | -8 | -5 | -8 | 23 | -13 | 0 |
2/21/12 18:00 | 2/16/12 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelly James Patrick | MD | O | SVP,CFO, | S.d | -23 | 4.67 | 1 | -5 | -28 | 13 | D | -56 | -35 | -13 | -11 | 3 | -4 | -11 | -2 | 0 | 4 | 7 | -12 | -10 | -14 |